Pfizer Accused of Hiding Deaths in COVID-19 Vaccine Trials, Including ‘Subject 11141050’ in Kansas, Team Research Alleges
The Honourable Kris Kobach
Attorney General of Kansas
120 SW 10th Ave, 2nd Floor
Topeka, Kansas 66612
4th December 2024
RE: Undisclosed Vaccinated Death from Kansas in the C4591001 Trial at the Vaccine and Related Biological Products Advisory Committee (VRBPAC) on December 10, 2020
Dear Attorney-General Kobach:
My name is Dr. Jeyanthi Kunadhasan, and I am an anesthetist and perioperative physician in Australia. I am also a member of the DailyClout team of volunteers who are investigating the data, released on the Public Health and Medical Professionals for Transparency website[1], which formed the basis of the Food and Drug Administration’s Emergency Use Authorization (EUA) of Pfizer-BioNTech’s BNT162b2 mRNA COVID-19 vaccine. Additionally, I am Treasurer of the Australian Medical Professionals Society.[2]
I co-wrote the WarRoom/DailyClout Pfizer Documents Analysis reports 42[3] and 76[4], available on dailyclout.io. I am also a coauthor of “Forensic Analysis of the 38 Subject deaths in the 6-Month Interim Report of the Pfizer-BioNTech BNT162b2 mRNA Vaccine Clinical Trial,”[5] which is the first analysis of the Pfizer-BioNTech BNT162b2 mRNA vaccine original trial data by a group unaffiliated with the clinical trial sponsor.
I note with interest your lawsuit against Pfizer. I would like to draw your attention to an undisclosed participant death from Kansas that occurred the BNT162b2-vaccinated arm of Pfizer’s clinical trial as originally reported in War Room/DailyClout Report 89, ‘Researchers Find Pfizer Delayed Recording Vaccinated Deaths at Critical Juncture of EUA Process. Improper Delays in Reporting Deaths in the Vaccinated Led FDA to Misstate Vaccine’s Effectiveness, Influenced EUA Grant Decision.‘[6]
As you are aware, the findings of the clinical trial C4591001 reportedly supporting the safety and efficacy of the BNT162b2 mRNA vaccine, have been published twice. Polack et al. first published findings on December 10, 2020, one day prior to the FDA’s issuance of EUA, entitled, “Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine”[7]. Then, on September 15, 2021, Stephen J. Thomas, MD, et al. published, “Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months.”[8] The Polack NEJM publication stated, “All the trial data were available to all the authors, who vouch for its accuracy and completeness and for adherence of the trial to the protocol, which is available with the full text of this article at NEJM.org. An independent data and safety monitoring board reviewed efficacy and unblinded safety data.” (Polack et al., 2020)
The Polack paper disclosed six deaths — two in the BNT162b2 arm, and four in the Placebo arm. In the journal article and the EUA approval documentation[9], the six deaths covered the period of July 27, 2020, through November 14, 2020. This letter will demonstrate that Pfizer-BioNTech possessed records showing that eight deaths, four in the BNT162b2 arm and four in the Placebo arm, should have been disclosed by Pfizer to the FDA. In addition, the two undisclosed deaths presented a cardiac event signal in the clinical trial’s BNT162b2 recipients. One of the undisclosed deaths in the vaccinated arm of the trial occurred in Kansas.
https://dailyclout.io/pfizer-did-not-disclose-a-kansas-vaccinated-sudden-cardiac-death-from-its-covid-19-clinical-trial-dr-jeyanthi-kunadhasans-letter-to-kansas-attorney-general-kris-kobach/